ATI LPN
PN ATI Capstone Proctored Comprehensive Assessment B Quizlet
1. A nurse is reviewing the laboratory results for a client who has end-stage liver disease. Which of the following findings should the nurse expect?
- A. Elevated albumin
- B. Elevated ammonia
- C. Decreased total bilirubin
- D. Decreased prothrombin time
Correct answer: B
Rationale: In end-stage liver disease, the liver's inability to convert ammonia into urea leads to elevated ammonia levels. Elevated ammonia levels can result in hepatic encephalopathy, a serious complication. Therefore, the correct answer is B. Elevated albumin (Choice A) is not typically seen in end-stage liver disease as liver dysfunction often leads to decreased albumin levels. Decreased total bilirubin (Choice C) is unlikely in end-stage liver disease, as bilirubin levels tend to be elevated due to impaired liver function. Decreased prothrombin time (Choice D) is also not expected in end-stage liver disease, as impaired liver function results in prolonged prothrombin time.
2. A client has a new prescription for metformin. Which of the following instructions should the nurse include in the teaching?
- A. Take the medication at bedtime
- B. Monitor your blood glucose level before each meal
- C. Stop taking the medication if you develop muscle pain
- D. You may experience diarrhea with this medication
Correct answer: D
Rationale: The correct answer is D: 'You may experience diarrhea with this medication.' Diarrhea is a common side effect of metformin, particularly when initiating the medication. It is important for clients to be aware of this potential side effect. Option A is incorrect because metformin is usually taken with meals to reduce gastrointestinal side effects. Option B is not directly related to metformin use. Option C is incorrect as muscle pain is not a common side effect of metformin and does not warrant stopping the medication.
3. A client with a history of renal failure is being cared for by a nurse. Which of the following should the nurse monitor?
- A. Fluid intake
- B. Electrolyte levels
- C. Blood pressure
- D. Both B and C
Correct answer: D
Rationale: Clients with renal failure are at risk for electrolyte imbalances and hypertension. Monitoring electrolyte levels is crucial because renal failure can lead to imbalances in sodium, potassium, and other electrolytes. Blood pressure monitoring is essential as hypertension is a common complication of renal failure. Therefore, both electrolyte levels and blood pressure should be closely monitored to detect and manage any abnormalities. Fluid intake, while important, is not specific to renal failure monitoring and is not the priority in this case.
4. A community health nurse is reviewing information about infectious diseases with the nurses on her team. The nurse should remind the team that which of the following diseases is included in the list of nationally notifiable infectious diseases?
- A. Influenza
- B. Tuberculosis
- C. Gonorrhea
- D. Hepatitis B
Correct answer: C
Rationale: The correct answer is Gonorrhea. Gonorrhea is a reportable sexually transmitted disease, and healthcare providers must report cases to the CDC to track and prevent outbreaks. Influenza, Tuberculosis, and Hepatitis B are not nationally notifiable infectious diseases. Influenza is monitored for its epidemiology and impact on public health, but it is not classified as nationally notifiable. Tuberculosis and Hepatitis B are not included in the list of diseases that healthcare providers are required to report to public health authorities.
5. A nurse is caring for a client prescribed the HMG CoA reductase inhibitor, atorvastatin. Which of the following should be monitored while this medication is prescribed?
- A. Liver function test
- B. Renal function test
- C. Hearing screenings
- D. Visual acuity screenings
Correct answer: A
Rationale: Corrected Rationale: Atorvastatin, an HMG CoA reductase inhibitor, can lead to hepatotoxicity. Therefore, monitoring liver function through regular tests is essential. Baseline liver function should be assessed, followed by tests at 12 weeks after starting therapy and periodically thereafter. This monitoring helps detect early signs of liver damage, including jaundice, nausea, and dark urine. Incorrect Choices Rationale: B) Renal function test is not directly affected by atorvastatin. C) Hearing screenings and D) Visual acuity screenings are not indicated for monitoring while on atorvastatin therapy.
Similar Questions
Access More Features
ATI LPN Basic
$69.99/ 30 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access
ATI LPN Premium
$149.99/ 90 days
- 5,000 Questions with answers
- All ATI courses Coverage
- 30 days access